Skip to main content
Premium Trial:

Request an Annual Quote

Kwokman Dx Gets FDA EUA for SARS-CoV-2 Molecular Testing Sample Collection Kit

NEW YORK — The US Food and Drug Administration last week granted Emergency Use Authorization for Kwokman Diagnostics' at-home nasal swab specimen collection kit for SARS-CoV-2 testing.

The Kwokman Diagnostics COVID-19 Home Collection Kit is designed for the at-home self-collection of anterior nasal swab specimens for use with in vitro diagnostics that detect SARS-CoV-2 RNA. The kit is for use by individuals at least 18 years old.

Testing of samples collected with the kit is limited to labs CLIA-certified to perform high-complexity tests and designed by Irvine, California-based Kwokman, according to the FDA.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.